Publications by authors named "Angela D Guerrera"
Article Synopsis
- Immune checkpoint inhibitors are a new class of cancer treatments that boost the immune system to target tumor cells and have shown improved survival rates for various cancers.
- Treatment with these inhibitors can lead to immune-mediated adverse reactions (IMARs) that mimic other conditions, commonly affecting the gastrointestinal, respiratory, endocrine, or skin systems.
- Emergency department staff need to recognize and manage IMARs differently from other cancer therapies, often using high-dose steroids, and should work closely with oncologists for effective treatment.
Background: Uncontrolled hypertension is associated with significant patient morbidity and health care costs. Many patients evaluated in the emergency department (ED) do not regularly consult health care providers and have socioeconomic barriers to receiving primary care. Hypertension screening and counseling has been advocated as a routine part of ED care.
View Article and Find Full Text PDF